Pharma BD Deal Intelligence
Supernus Pharmaceuticals, Inc. / Adamas Pharmaceuticals, Inc.
2021 · Acquisition/Merger · $450M · Pending
This deal is too recent to grade. Critic Score and Outcome Score are assigned after the announcement-week coverage settles and, for Outcome, after the 5-year post-close assessment window opens — expected 2026 at the earliest for this deal, once/if it closes.
Key facts
- Announced Oct 11, 2021
- Deal value $450M
- Deal type Acquisition/Merger
Related deals
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals
More: 2021 deals